HY0001a
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HY0001a, covering 2026-03-09 to 2026-03-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/Ⅱ Human Study of HY0001a for Injection in Adult Participants With Advanced Solid Tumors [Phase 1, Phase 2]